AtheroNova Inc. is a clinical stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. Atherosclerotic plaque, which progressively narrows and blocks arteries, is the main underlying pathology of cardiovascular disease and the leading killer in industrialized nations worldwide. The Company s focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi billion dollar prescription drug market: cardiovascular disease and stroke prevention. Key Investment Considerations Billion market potential Strong IP protection Identifiable milestones Potentially lower risk of safety or efficacy problems than is typical in drug development Strong management team with successful track record Capital structure
Quote | Atheronova Inc. (OTCMKTS:AHROQ)
Last: | $0.0011 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0011 |
Close: | $0.0011 |
High: | $0.0011 |
Low: | $0.0011 |
Volume: | 150,630 |
Last Trade Date Time: | 08/25/2021 04:40:11 am |
News | Atheronova Inc. (OTCMKTS:AHROQ)
Message Board Posts | Atheronova Inc. (OTCMKTS:AHROQ)
Subject | By | Source | When |
---|---|---|---|
znewcar1: AHRO 25% v37,9M f1,534B hod.0038 | znewcar1 | investorshangout | 02/17/2023 3:23:43 PM |
AHROQ registration revoked: | Renee | investorshub | 09/08/2021 1:38:11 PM |
AHROQ SEC Suspension for severely delinquent Financials: | Renee | investorshub | 05/20/2021 2:52:45 PM |
$AHROQ: Told you it was gonna continue to DROP | makinezmoney | investorshub | 09/14/2017 4:30:22 PM |
$AHROQ: Bidding $0.0045 on it......... | makinezmoney | investorshub | 09/13/2017 2:09:59 PM |
News, Short Squeeze, Breakout and More Instantly...